首页> 外国专利> A New Association Drug delayed release

A New Association Drug delayed release

机译:新协会药物延迟发布

摘要

The present invention relates to procedures for the synthesis and acquisition of oral drugs, in particular for the treatment and / or prevention of cardiovascular diseases and / or their physical signs and / or symptoms, such as thoracic angioplasty, myocardial infarction and / or the synthesis of physical signs. Other cardiovascular diseases include heart disease, cerebrovascular disease and trauma. More specifically, the invention relates to a mixed formulation of acetyl acrylic acid - an effective anti-inflammatory agent, painkiller and drug resistance,For the treatment of rheumatoid arthritis or osteoarthritis and isosorb 5-mononitrate, wherein isosorb 5-mononitrate is transported in the form of predetermined release, as well as acetylhydrochloric acid transported in many ways, Similar to isosorb 5-mononitrate, or granulated, even in the form of coated glass.
机译:本发明涉及合成和获得口服药物的方法,特别是用于治疗和/或预防心血管疾病和/或它们的物理体征和/或症状,例如胸腔血管成形术,心肌梗塞和/或合成方法。体征。其他心血管疾病包括心脏病,脑血管疾病和创伤。更具体地说,本发明涉及一种用于治疗类风湿性关节炎或骨关节炎和异山梨醇5-单硝酸盐的乙酰丙烯酸-一种有效的消炎药,止痛药和耐药性的混合制剂,其中异山梨醇5-单硝酸盐在体内被转运。形式的预定释放,以及以许多方式运输的乙酰盐酸,与等吸收型5-一硝酸酯相似,或成粒状,甚至以涂层玻璃的形式存在。

著录项

  • 公开/公告号UY26356A1

    专利类型

  • 公开/公告日2000-10-31

    原文格式PDF

  • 申请/专利权人 LIBBS FARMACEUTICA LTDA.;

    申请/专利号UY20000026356

  • 发明设计人 ALCEBIADES DE MENDONCA ATHAYDENCA ATHAYDE;

    申请日2000-09-26

  • 分类号A61K9/16;A61K9/20;A61K9/26;A61K9/50;A61K9/58;A61K31/34;A61K31/40;A61K31/60;A61K47/30;A61P9/10;

  • 国家 UY

  • 入库时间 2022-08-22 01:54:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号